research Associations of telogen effluvium with coronavirus disease 2019 and research progress in its diagnosis and treatment
COVID-19 may cause common hair loss due to stress, immune response, medications, and other health issues.
Search
for
Sort by
Research
960-990 / 1000+ results 
research Viral-Induced Rapidly Progressive Alopecia Universalis: A Case Report and Literature Review
COVID-19 may trigger or worsen rapid hair loss in alopecia areata.
research Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.
research PATHOGENETIC FEATURES OF THE INFLUENCE OF A PAST CORONAVIRUS INFECTION IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
Women with PCOS are more vulnerable to severe COVID-19 and related health issues.
research Platelet-Rich Plasma Therapy with Excelents Results in the Treatment of Post-Infectious Telogen Effluvium
Platelet-Rich Plasma therapy helped significantly in hair recovery for a hair loss condition after infection.
research EFLÚVIO TELÓGENO PÓS-INFECÇÃO POR SARS-COV-2
COVID-19 can cause temporary hair loss in some people.
research Intermittent chronic telogen effluvium with an unusual dermoscopic finding
A 17-year-old girl has had repeated hair loss since childhood, which can be triggered by infections like COVID-19.
research Peculiarities of clinical course and diagnostic of alopecia areata with comorbidity. Clinical observations
Alopecia areata is complex, often recurring, and needs personalized treatment, especially with other health issues.
research Alopecia androgênica como agravo da infecção por SARS-CoV-2
People with androgenetic alopecia may have a higher risk of severe COVID-19.
research Потеря волос, ассоциированная с COVID‑19: проблема и пути решения
COVID-19 can cause temporary hair loss due to stress and inflammation.
research The changing landscape of managing hair loss: a 30‐year perspective
There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.
research Excessive hair loss as a complication after infection with SARS-CoV-2 virus
Some people lose a lot of hair after having COVID-19.
research Examining Alopecia through Selected Case Studies in Bangladesh
The pandemic stress may have increased alopecia cases in Bangladesh.
research I CONGRESSO NACIONAL ACADÊMICO DE DERMATOLOGIA
The I National Academic Congress of Dermatology in 2021 expanded to include participants from across Brazil and discussed dermatology topics, including COVID-19.
research Reply to comment on: The Gabrin sign
Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.
research Epidemiological Analysis of Alopecia in Migrant Communities at Dr. Hair™ Clinics
Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.
research Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials
Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.
research Photobiostimulation Therapy (PBST) and Pulsed Electromagnetic Field Therapy (PEMF) in Hair Loss Treatment: Multicentric, Retrospective, Case–Control Study
Combining PEMF with PBST is more effective for hair regrowth than PBST alone.
research Breaking bald: Unraveling the mysteries of hair loss and modern treatments
Hair loss has many causes and treatments, but future research aims for better solutions.
research A Study of the Clinical Patterns of Hair Loss in Female Patients
Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.
research Telogen effluvium: a 360 degree review
Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.
research Eflúvio Telógeno pós-COVID: uma revisão integrativa
COVID-19 can cause temporary hair loss.
research Post COVID complications
COVID-19 survivors may face long-term health issues affecting both mind and body.
research SARS‐CoV‐2 & androgenic alopecia: exploring links!
Possible link between COVID-19 and hair loss; more research needed.
research Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us?
The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.
research AVALIAÇÃO DO USO DE TELAS DIGITAIS POR CRIANÇAS E ADOLESCENTES EM TEMPOS DE PANDEMIA
Children's screen time increased during the pandemic, causing various health issues.
research Analysis of post-COVID symptoms and predisposing factors for chronic post-COVID syndrome
Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.
research The impact of healthcare setting on post-COVID mood disorders: a single-centre perspective from Southern Italy Respiratory Intensive Care Unit
Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.
research 新型コロナウイルス感染症後遺症の脱毛に人参養栄湯が有効であった2例
Ninjin'yoeito, a Japanese medicine, helped stop hair loss and improved mood in two post-COVID-19 patients.
research Androgenetic alopecia and COVID ‐19: A review of the hypothetical role of androgens
Possible link between androgens and COVID-19 severity; more research needed.